Lantheus Holdings Inc (LNTH) - Net Assets

Latest as of December 2025: $1.09 Billion USD

Based on the latest financial reports, Lantheus Holdings Inc (LNTH) has net assets worth $1.09 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.23 Billion) and total liabilities ($1.14 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Lantheus Holdings Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	$1.09 Billion
% of Total Assets	48.93%
Annual Growth Rate	N/A
5-Year Change	134.65%
10-Year Change	N/A
Growth Volatility	117.78

Lantheus Holdings Inc - Net Assets Trend (2012–2025)

This chart illustrates how Lantheus Holdings Inc's net assets have evolved over time, based on quarterly financial data. Also explore how large is Lantheus Holdings Inc's balance sheet for the complete picture of this company's asset base.

Annual Net Assets for Lantheus Holdings Inc (2012–2025)

The table below shows the annual net assets of Lantheus Holdings Inc from 2012 to 2025. For live valuation and market cap data, see market cap of Lantheus Holdings Inc.

Year	Net Assets	Change
2025-12-31	$1.09 Billion	+0.16%
2024-12-31	$1.09 Billion	+33.35%
2023-12-31	$815.89 Million	+82.47%
2022-12-31	$447.15 Million	-3.72%
2021-12-31	$464.44 Million	-9.68%
2020-12-31	$514.21 Million	+348.69%
2019-12-31	$114.60 Million	+61.41%
2018-12-31	$71.00 Million	+204.85%
2017-12-31	$23.29 Million	+121.87%
2016-12-31	$-106.52 Million	+42.51%
2015-12-31	$-185.29 Million	+22.56%
2014-12-31	$-239.27 Million	-1.59%
2013-12-31	$-235.52 Million	-36.05%
2012-12-31	$-173.10 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Lantheus Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 95880200000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	$679.50 Million	62.35%
Common Stock	$718.00K	0.07%
Other Comprehensive Income	$-1.31 Million	-0.12%
Other Components	$410.88 Million	37.70%
Total Equity	$1.09 Billion	100.00%

Lantheus Holdings Inc Competitors by Market Cap

The table below lists competitors of Lantheus Holdings Inc ranked by their market capitalization.

Company	Market Cap
Apogee Therapeutics, Inc. Common Stock NASDAQ:APGE	$4.93 Billion
Delek Group TA:DLEKG	$4.94 Billion
Sonoco Products Company NYSE:SON	$4.94 Billion
Teleflex Incorporated NYSE:TFX	$4.94 Billion
Outfront Media Inc NYSE:OUT	$4.93 Billion
Hess Midstream Partners LP NYSE:HESM	$4.93 Billion
Cochin Shipyard Limited NSE:COCHINSHIP	$4.93 Billion
Sectra AB (publ) ST:SECT-B	$4.93 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Lantheus Holdings Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 1,088,011,000 to 1,089,797,000, a change of 1,786,000 (0.2%).
Net income of 233,559,000 contributed positively to equity growth.
Share repurchases of 300,017,000 reduced equity.
New share issuances of 3,727,000 increased equity.
Other comprehensive income increased equity by 308,000.
Other factors increased equity by 64,209,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	$233.56 Million	+21.43%
Share Repurchases	$300.02 Million	-27.53%
Share Issuances	$3.73 Million	+0.34%
Other Comprehensive Income	$308.00K	+0.03%
Other Changes	$64.21 Million	+5.89%
Total Change	$-	0.16%

Book Value vs Market Value Analysis

This analysis compares Lantheus Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 5.37x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	$-9.57	$85.50	x
2013-12-31	$-12.80	$85.50	x
2014-12-31	$-13.23	$85.50	x
2015-12-31	$-7.58	$85.50	x
2016-12-31	$-3.26	$85.50	x
2017-12-31	$0.60	$85.50	x
2018-12-31	$1.80	$85.50	x
2019-12-31	$2.86	$85.50	x
2020-12-31	$9.50	$85.50	x
2021-12-31	$6.88	$85.50	x
2022-12-31	$6.33	$85.50	x
2023-12-31	$11.62	$85.50	x
2024-12-31	$15.18	$85.50	x
2025-12-31	$15.92	$85.50	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Lantheus Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 21.43%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 15.15%
• Asset Turnover: 0.69x
• Equity Multiplier: 2.04x
Recent ROE (21.43%) is below the historical average (49.50%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	0.00%	-14.58%	0.89x	0.00x	$-24.69 Million
2013	0.00%	-21.70%	1.09x	0.00x	$-38.00 Million
2014	0.00%	-1.18%	1.21x	0.00x	$20.37 Million
2015	0.00%	-5.02%	1.21x	0.00x	$3.78 Million
2016	0.00%	8.87%	1.18x	0.00x	$37.41 Million
2017	529.75%	37.23%	0.86x	16.48x	$121.06 Million
2018	57.07%	11.80%	0.78x	6.19x	$33.42 Million
2019	27.63%	9.12%	0.86x	3.54x	$20.21 Million
2020	-2.62%	-3.97%	0.39x	1.69x	$-64.89 Million
2021	-15.35%	-16.76%	0.49x	1.86x	$-117.72 Million
2022	6.28%	3.00%	0.71x	2.95x	$-16.65 Million
2023	40.04%	25.20%	0.79x	2.02x	$245.07 Million
2024	28.72%	20.37%	0.77x	1.82x	$203.64 Million
2025	21.43%	15.15%	0.69x	2.04x	$124.58 Million

Industry Comparison

This section compares Lantheus Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $236,113,024
Average return on equity (ROE) among peers: -47.06%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Lantheus Holdings Inc (LNTH)	$1.09 Billion	0.00%	1.04x	$4.93 Billion
Aurora Cannabis Inc (ACB)	$602.92 Million	-11.50%	0.39x	$197.35 Million
Akanda Corp (AKAN)	$-3.83 Million	0.00%	0.00x	$1.51 Million
Akebia Ther (AKBA)	$74.01 Million	-330.87%	6.15x	$340.21 Million
Alkermes Plc (ALKS)	$54.20 Million	-73.99%	0.03x	$4.62 Billion
Amylyx Pharmaceuticals Inc (AMLX)	$-25.36 Million	0.00%	0.00x	$1.77 Billion
Amphastar P (AMPH)	$639.42 Million	21.51%	1.37x	$959.02 Million
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)	$346.79 Million	-104.36%	9.57x	$3.81 Billion
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)	$344.93 Million	26.40%	10.61x	$3.57 Billion
Anika Therapeutics Inc (ANIK)	$287.08 Million	1.44%	0.21x	$199.00 Million
ANI Pharmaceuticals Inc (ANIP)	$40.96 Million	0.73%	0.09x	$1.80 Billion

About Lantheus Holdings Inc

NASDAQ:LNTH USA Drug Manufacturers - Specialty & Generic

Market Cap

$5.67 Billion

Market Cap Rank

#3624 Global

#1227 in USA

Share Price

$85.50

Change (1 day)

+1.04%

52-Week Range

$50.11 - $107.98

All Time High

$123.62